Easywell Biomedicals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 12, 2020 at 02:06 pm EDT
Share
Easywell Biomedicals, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 67.791 million compared to TWD 107.537 million a year ago. Operating loss was TWD 52.485 million compared to TWD 57.817 million a year ago. Net loss was TWD 54.330 million compared to TWD 66.334 million a year ago. Basic loss per share from continuing operations was TWD 0.42 compared to TWD 0.54 a year ago. Basic loss per share was TWD 0.42 compared to TWD 0.61 a year ago. For the half year, sales was TWD 145.627 million compared to TWD 191.261 million a year ago. Operating loss was TWD 97.729 million compared to TWD 112.069 million a year ago. Net loss was TWD 100.121 million compared to TWD 128.890 million a year ago. Basic loss per share from continuing operations was TWD 0.79 compared to TWD 1.07 a year ago. Basic loss per share was TWD 0.79 compared to TWD 1.21 a year ago.
Easywell Biomedicals Inc. is a Taiwan-based company principally engaged in the research, development, production and sale of raw materials and temperature measurement products. The raw materials are applied in the manufacture of medicament for the treatment of epilepsy, pain and fever, antihypertensive and diuretic, skeletal muscle relaxants, among others. The Company's diagnostic devices include ear thermometers and digital clinical thermometers. The Company distributes its products mainly in Taiwan, the Americas and Europe.
EASYWELL BIOMEDICALS, INC. 
